The UK stands at the cusp of a new era of medical breakthroughs, fuelled by the increased use of data and the recent plans to open NHS data reserves to improve the development and creation
As the race to deliver personalised engagement at scale gains pace, artificial intelligence (AI) has become a critical differentiator for pharma companies.